Connection

Konstantinos Syrigos to Anticoagulants

Back to Details
This is a "connection" page, showing publications Konstantinos Syrigos has written about Anticoagulants.
Konstantinos Syrigos
Connection Strength
0.754
Anticoagulants
  1. Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study. In Vivo. 2021 Jan-Feb; 35(1):653-661.
    View in: PubMed
    Score: 0.192
  2. Heterogeneity in reporting venous thromboembolic phenotypes in COVID-19: methodological issues and clinical implications. Br J Haematol. 2020 08; 190(4):529-532.
    View in: PubMed
    Score: 0.186
  3. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action. Br J Haematol. 2020 06; 189(5):846-847.
    View in: PubMed
    Score: 0.183
  4. The use of novel oral anticoagulants in cancer patients with venous thromboembolism. Semin Oncol. 2016 Dec; 43(6):655-665.
    View in: PubMed
    Score: 0.144
  5. Thromboprophylaxis in COVID-19: Early initiation might be as important as optimal dosing. Thromb Res. 2021 08; 204:134-135.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.